IDH2 and leukemia: Currently, there is a lack of authoritative research on the mechanisms by which IDH mutations contribute to PPGLs pathogenesis and progression, although the oncogenic mechanisms of IDH mutations have been extensively studied in diseases like gliomas and leukemias.